SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 03 Jun 2021
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
85835756 filed on 29th Jan 2013
Registration Number
4712947 registered on 31st Mar 2015
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
BLINCYTO
Pharmaceutical preparations for use in the treatment of tumorous diseases, B-cell disorders, autoimmune diseases, inflammation, infectious diseases and minimal residual disease
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in the treatment of tumorous diseases, B-cell disorders, autoimmune diseases, inflammation, infectious diseases and minimal residual disease
First Use Date in General
17th Dec 2014
First Use Date in Commerce
17th Dec 2014
Mark Details
Serial Number
No 85835756
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM-1049-US-1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Mar 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 29th Apr 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 29th Apr 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 29th Apr 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 29th Apr 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 29th Apr 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 29th Apr 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 03rd Jun 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 03rd Jun 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 03rd Jun 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |